GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Kate Spade & Company (KATE) [hlAlert]

Rating:
Outperform
FNP
up 32.58 %

Fifth & Pacific Companies (FNP) rated Outperform with price target $40 by Imperial Capital

Posted on: Tuesday,  Dec 10, 2013  8:25 AM ET by Imperial Capital

Imperial Capital rated Outperform Kate Spade & Company (NYSE: KATE) on 12/10/2013. Previously Imperial Capital rated Outperform Kate Spade & Company (NYSE: KATE)
on 01/04/2013., when the stock price was $13.38. Since then, Kate Spade & Company has gained 32.59% as of 11/02/2015's recent price of $17.74.
If you would have followed the previous Imperial Capital's recommendation on KATE, you would have gained 32.58% of your investment in 1032 days.

Liz Claiborne, Inc. (LizClaiborne), incorporated in January 1976, designs and markets a global portfolio of retail-based brands, including JUICY COUTURE, KATE SPADE, LUCKY BRAND JEANS and MEXX. It also have a group of department store-based brands with strong consumer franchises, including the LIZ CLAIBORNE and MONET families of brands, MAC & JAC, KENSIE and DANA BUCHMAN and the licensed DKNY JEANS, DKNY ACTIVE and DKNY MENS brands. The three segments of the Company are Domestic-Based Direct Brands segment, International-Based Direct Brands segment and Partnered Brands segment. On January 17, 2008, the Company entered into a license agreement with Kohl?s Corporation (Kohl?s), naming Kohl?s as the exclusive retailer of its DANA BUCHMAN brand. In April 2008, the Company completed the sale of substantially all of the assets and liabilities of the Ellen Tracy brand.

Imperial Capital
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/10/2013 8:25 AM Buy
None
33.75 40.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/20/2013 10:25 AM Buy
None
24.96 30.00
2/7/2013 2:25 PM Buy
None
16.58 25.00
1/4/2013 11:25 AM Buy
None
13.38 18.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy